VALN Competitors & Alternatives
Compare Valneva SE ADR with similar stocks in the same industry
Biotechnology
VALN
Main Stock$5.26
Tradestie Score
52
Market Cap
$993.46M
Revenue Growth
-0.3%
Analyst Upside
+132.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$2.35
|
$552.46M | - | 66 | Compare |
|
VSTM
Verastem, Inc.
|
$9.94
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.41
|
$540.97M | - | 57 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.87
|
$529.35M | 11.4 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.40
|
$512.39M | - | 46 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.84
|
$505.12M | 2.8 | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.91
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.16
|
$468.01M | - | 48 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.71
|
$463.20M | - | 47 | Compare |
More VALN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry